CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-09 | POON CHRISTINE A Director | Option exercise | +15,000 | $177.82 | $2.7M | 16,872 |
| 2022-08-09 | POON CHRISTINE A Director | Sale | −6,814 | $620.47 | $4.2M | 10,058 |
| 2022-08-09 | POON CHRISTINE A Director | Sale | −8,186 | $621.27 | $5.1M | 1,872 |
| 2022-08-09 | POON CHRISTINE A Director | Option exercise · Non-Qualified Stock Option (right to buy) | −15,000 | 0 | ||
| 2022-08-05 | STAHL NEIL EVP Research and Development | Sale | −176 | $606.78 | $107K | 76,401 |
| 2022-08-05 | STAHL NEIL EVP Research and Development | Sale | −724 | $607.47 | $440K | 75,677 |
| 2022-08-05 | STAHL NEIL EVP Research and Development | Sale | −610 | $608.70 | $371K | 75,067 |
| 2022-08-05 | STAHL NEIL EVP Research and Development | Sale | −3,044 | $609.62 | $1.9M | 72,023 |
| 2022-08-05 | STAHL NEIL EVP Research and Development | Sale | −3,931 | $610.49 | $2.4M | 68,092 |
| 2022-08-05 | STAHL NEIL EVP Research and Development | Sale | −2,022 | $611.44 | $1.2M | 66,070 |
| 2022-08-05 | STAHL NEIL EVP Research and Development | Sale | −2,076 | $612.43 | $1.3M | 63,994 |
| 2022-08-05 | STAHL NEIL EVP Research and Development | Sale | −3,218 | $613.49 | $2.0M | 60,776 |
| 2022-08-05 | STAHL NEIL EVP Research and Development | Sale | −4,112 | $614.35 | $2.5M | 56,664 |
| 2022-08-05 | STAHL NEIL EVP Research and Development | Sale | −1,610 | $615.49 | $991K | 55,054 |
| 2022-08-05 | STAHL NEIL EVP Research and Development | Sale | −535 | $616.40 | $330K | 54,519 |
| 2022-08-05 | STAHL NEIL EVP Research and Development | Sale | −424 | $617.43 | $262K | 54,095 |
| 2022-08-05 | STAHL NEIL EVP Research and Development | Sale | −521 | $618.27 | $322K | 53,574 |
| 2022-08-05 | STAHL NEIL EVP Research and Development | Sale | −502 | $619.64 | $311K | 53,072 |
| 2022-08-05 | STAHL NEIL EVP Research and Development | Sale | −177 | $620.11 | $110K | 52,895 |
| 2022-08-05 | STAHL NEIL EVP Research and Development | Sale | −100 | $621.11 | $62K | 52,795 |
Page 76 of 105 · 2,088 trades